Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Current controversies in the surgical management of colorectal cancer metastases to the liver Small R; Lubezky N; Ben-Haim MIsr Med Assoc J 2007[Oct]; 9 (10): 742-7Surgical resection offers the best opportunity for cure in patients with colorectal cancer metastasis to the liver, with 5 year survival rates of up to 58% following resection. However, only a small percentage of patients are eligible for resection at the time of diagnosis and the average recurrence rate is still high. Consequently, research endeavors have focused on methods aimed at increasing the number of patients eligible for surgical resection, refining the selection criteria for surgery, and improving the disease-free and overall survival time in these patients. Improvements in imaging techniques and the increasing use of FDG-PET allow more accurate preoperative staging and superior identification of patients likely to benefit from surgical resection. Advances in the use of neoadjuvant chemotherapy allow up to 38% of patients previously considered unresectable to be significantly downstaged and eligible for hepatic resection. Many reports have critically evaluated the surgical techniques applied to liver resection, the concurrent or alternative use of local ablative therapies, such as radiofrequency ablation, and the subsequent use of adjuvant chemotherapy in patients undergoing surgical resection for hepatic metastases.|Catheter Ablation[MESH]|Chemotherapy, Adjuvant[MESH]|Colorectal Neoplasms/drug therapy/*pathology/*surgery[MESH]|Humans[MESH]|Liver Neoplasms/drug therapy/*secondary/*surgery[MESH]|Neoadjuvant Therapy[MESH]|Recurrence[MESH]|Time Factors[MESH]|Tomography, Emission-Computed[MESH] |